Business Wire IndiaKnown as the leading, award-winning, and most trusted forex brokers of 2021, TP Global FX has expanded its foothold to Dubai on 24th September by inaugurating their new…
Business Wire India Dr Hermann Hauser, serial entrepreneur, co-founder of Amadeus Capital Partners and founder of semiconductor company, Arm Ltd, and gene-sequencing company, Solexa / Illumina, joins as chair of…
Business Wire IndiaWNS (Holdings) Limited (WNS) (NYSE: WNS), a leading provider of global Business Process Management (BPM) solutions, today announced results for the fiscal 2022 second quarter ended September 30,…
Business Wire India Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) announced that its Board of Directors resolved today to engage in the acquisition of its own shares pursuant to the provision…
Business Wire India Delivered H1 Year-Over-Year Growth in Reported Revenue of +12.8% and Underlying Revenue of +6.8% 14 Global Brands Represent 42% of Total Core Revenue with +11.4% Underlying Growth…
Business Wire India OZiva, India’s leading certified clean, plant-based nutrition and wellness brand, recently announced its entry into the kids nutrition segment with the launch of OZiva Kids. Research states…
Business Wire IndiaIndian School Awards was organised by Kiteskraft Productions to pay accolades to recognize and reward quality excellence, innovative initiatives and exemplary work in the Education Sector in a…
Business Wire India The FiRa™ Consortium, a catalyst for bringing leading innovators together to drive Ultra-Wideband (UWB) expansion, is today announcing two milestones in the market acceptance of UWB technology.…
Business Wire India Fluence, a leading global provider of energy storage products and services and digital applications for renewables and storage, today announced the pricing of its initial public offering…
Business Wire India − Acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging γδT cells for the potential treatment of solid tumors and hematological malignancies…
